APOL1 and kidney disorder: Since only a proportion of individuals that present APOL1 risk genotypes develops kidney disease, studies considering long-term outcomes of individuals with APOL1 risk genotypes and allograft survival from donors with the APOL1 risk genotypes will be useful to guide APOL1 genetic testing and understand the status of APOL1 risk variants in nephrology (Young et al., 2017).